Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma

19 Oct 2022

Abstract excerpt

Abstract To investigate the role of patient-derived organoid (PDO) model in the precision medicine of advanced clear cell renal cell carcinoma (ccRCC), we retrospectively analyzed the clinical data of seven cases of ccRCC diagnosed by operation and pathology in Renji Hospital from September 2021 to September 2022. The seven patients were diagnosed with advanced ccRCC with or without remote metastasis....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36544542
DOI: 10.1093/pcmedi/pbac028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinomaPMID 36544542Read ↗

Patient-derived renal cell carcinoma organoids for precision medicineSemantic proximity Read ↗

The establishment of kidney cancer organoid line in drug testing.Semantic proximity Read ↗

Treatment strategies for clear cell renal cell carcinoma: Past, present and futureSemantic proximity Read ↗

CASP5 associated with PANoptosis promotes tumorigenesis and progression of clear cell renal cell carcinomaSemantic proximity Read ↗

AC010973.2 Promotes Cell Proliferation and Is One of Six Stemness-Related Genes That Predict Overall Survival of Renal Clear Cell CarcinomaSemantic proximity Read ↗

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agentsSemantic proximity Read ↗

Pseudocapsule Thickness is Positively Associated with Prognosis in Patients with Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotypeSemantic proximity Read ↗

Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade.Semantic proximity Read ↗

Chemotherapy, Immunotherapy, and Surgery Should be Optimal Treatment Choices of Metastatic Sarcomatoid Renal Cell CarcinomaSemantic proximity Read ↗

A systems-level machine learning approach uncovers therapeutic targets in clear cell renal cell carcinomaSemantic proximity Read ↗

Renal Cell Carcinoma in a Transplanted Kidney: a retrospective evaluationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.